Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function

Pediatric Pulmonology

Volumn 43, Issue 2, 2008, Pages 134-141

  Paro Heitor, Maria Luisa Z ^a   Bussamra, Maria Helena C F ^a   Saraiva Romanholo, Beatriz M ^a   Martins, Milton A ^a   Okay, Thelma Suely ^a   Rodrigues, Joaquim Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Airway inflammation; Childhood asthma; Fractional exhaled nitric oxide; Inhaled corticosteroids; Interleukins; Pulmonary function; Sputum analysis

Indexed keywords

FLUTICASONE; FLUTICASONE PROPIONATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; NITRIC OXIDE;

ADOLESCENT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CYTOLOGY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SCHOOL CHILD; SPIROMETRY; SPUTUM ANALYSIS;

EID: 39449130842     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20747     Document Type: Article

References (38)

1. National Heart Lung and Blood Institute, National Institute for Health. Global strategy for asthma management and prevention: NHLB1/WHO workshop report. Bethesda; revised, 2006.
2. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005;171:1077-1082.
3. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric-oxide, and breath condensate. Eur Respir J 2000;16:1008-1015.
4. Horváth I, Hunt J, Barnes PJ. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-548.
5. Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McFachlan CR, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002;20:601-608.
6. Rosias PP, Dompeling E, Dentener MA, Pennings HJ, Hendriks HJ, Van Iersel MP, et al. Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 2004;38:107-114.
7. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006;61:817-827.
8. Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Speradio S, et al. Exhaled nitric oxide and eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999;13:1386-1390.
9. American Thoracic Society. Definitions and classifications of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Resp Dis 1962;85:762-764.
10. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160:2104-2117.
11. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 2007;152:1107-1136.
12. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-29.
13. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996: 308-317.
14. Saraiva-Romanholo BM, Barnabe V, Carvalho AL, Martins MA, Saldiva PH, Nunes MP. Comparison of three methods for differential cell count in induced sputum. Chest 2003;124:1060-1066.
15. Hansel TT. How do we measure the effectiveness of inhaled corticosteroids in clinical studies? Respir Med 2004;98:S9-S15.
16. Carra S, Gagliardi L, Zanconato S, Scollo M, Azzolin N, Zacchello F, et al. Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. Respir Med 2001;95:734-739.
17. Pijnenburg MW, Bakker EM, Fever S, Hop WC, De Jongste JC. High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Clin Exp Allergy 2005;35:920-925.
18. Buchvald F, Baraldi E, Carraro S, Gaston B, De JJ, Pijnenburg MW, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005;115:1130-1136.
19. Buchvald F, Eiberg H, Bisgaard H. Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin Exp Allergy 2003;33:1735-1740.
20. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-2173.
21. Zeidler MR, Kleerup EC, Tashkin DP. Exhaled nitric oxide in the assessment of asthma. Curr Opin Pulm Med 2004;10:31-36.
22. Covar RA, Szeller SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003;142:469-475.
23. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003;112:883-892.
24. Langley SJ, Goldthorpe S, Custovic A, Woodcock A. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol 2003;91:398-404.
25. Colon-Semidey AJ, Marshik P, Crowley M, Katz R, Kelly HW. Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma. Pediatr Pulmonol 2000;30:385-392.
26. Li AM, Tsang TW, Chan K, Chan DF, Sung RY, Fok TF. Once-daily fluticasone propionate in stable asthma: study on airway inflammation. J Asthma 2006;43:107-111.
27. Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;19:1015-1019.
28. Pijnenburg MW, Floor SE, Hop WC, De Jongste JC. Daily ambulatory exhaled nitric oxide measurements in asthma. Pediatr Allergy Immunol 2006;17:189-193.
29. Kharitonov SA, Barnes PJ. Effects of corticosteroids on non-invasive biomarkers of inflammation in asthma and chronic-obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:191-199.
30. Prescott SL. New concepts of cytokines in asthma: is the Th2/Th1 paradigm out the window? J Paediatr Child Health 2003;39:575-579.
31. Kips JC. Cytokines in asthma. Eur Respir J Suppl 2001;34:24s-33s.
32. O'Byrne PM. Cytokines or their antagonists for the treatment of asthma. Chest 2006;130:244-250.
33. Wilson NM, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000;55:768-774.
34. Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum cosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J 1998;11:848-853.
35. Palomino AF, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Nunes MP, Rodrigues JC. Induced sputum in children and adolescents with asthma: safety, clinical applicability and inflammatory cells aspects in stable patients and during exacerbation. J Pediatr (Rio J) 2005;81:216-224.
36. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001;163:1470-1475.
37. Gibson PG. Use of induced sputum to examine airway inflammation in childhood asthma. J Allergy Clin Immunol 1998;102:S100-S101.
38. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721.